Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer (IMMU-132-13) (PSCI# 20-090)

Phase III Study of Sacituzumab Govitecan Versus standard of care medications in patients with Urothelial Cancer that has spread or is not a surgical candidate.
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04527991
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Metastatic or local unresectable Urethral Cancer
Subjects with recurrence or progression ≤12 months following completion of cisplatin chemotherapy
Subjects who received either carboplatin or anti PD-1/PD-L1 therapy
Exclusion Criteria:
Women who are pregnant or lactating.
Have had a prior chempotherapy within 4 weeks prior to C1D1
Have an active second cancer.
Have active cardiac disease
Cancer
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA